NSE BSE
global health limited stock

GLOBAL HEALTH LIMITED Share Price

- - (%)
- NSE: MEDANTA

GLOBAL HEALTH LIMITED Share Price Update

As of the latest trading session, GLOBAL HEALTH LIMITED share price is currently at 1204.3, which is up by 0.20 from its previous closing. Today, the stock has fluctuated between 1199.95 and 1214.40. Over the past year, GLOBAL HEALTH LIMITED has achieved a return of 71.29 %. In the last month alone, the return has been -10.87 %. Read More...

GLOBAL HEALTH LIMITED Performance

Day Range

Low1199.95 High1214.40
1204.30

52 Week Range

Low 655.65 High 1513.90
1204.30

GLOBAL HEALTH LIMITED Share Price

11956

543654

MEDANTA

img img img img
No Data Available

Open Price

1204.10

Prev. Close

1204.10

Volume (Shares)

544561.00

Total traded value

6558.14

Upper Circuit

1444.90

Lower Circuit

963.30

Note: The current prices & values are delayed, Login to your account for live updates.

GLOBAL HEALTH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 30495.76
PE Ratio (TTM) 89.47
Book Value / Share 106.09
Beta 0.55
ROE 13.52%
EPS (TTM) 13.42
Dividend Yield 0.00%
Net Profit Qtr (Cr) 92.24

GLOBAL HEALTH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 578.65
Operating Expense 486.03
Net Profit 92.24
Net Profit Margin (%) 15.94
Earnings Per Share (EPS) 3.43
EBITDA 154.76
Effective Tax Rate (%) 26.30
Particulars DEC 2023 (Values in Cr)
Revenue 564.84
Operating Expense 466.64
Net Profit 87.34
Net Profit Margin (%) 15.46
Earnings Per Share (EPS) 3.25
EBITDA 148.36
Effective Tax Rate (%) 27.74
Particulars SEP 2023 (Values in Cr)
Revenue 580.15
Operating Expense 479.49
Net Profit 95.10
Net Profit Margin (%) 16.39
Earnings Per Share (EPS) 3.54
EBITDA 154.54
Effective Tax Rate (%) 25.06
Particulars JUN 2023 (Values in Cr)
Revenue 544.59
Operating Expense 462.05
Net Profit 86.21
Net Profit Margin (%) 15.83
Earnings Per Share (EPS) 3.10
EBITDA 142.54
Effective Tax Rate (%) 25.51
Particulars MAR 2023 (Values in Cr)
Revenue 506.16
Operating Expense 426.82
Net Profit 80.96
Net Profit Margin (%) 15.99
Earnings Per Share (EPS) 3.02
EBITDA 130.92
Effective Tax Rate (%) 22.30
Particulars MAR 2024 (Values in Cr)
Revenue 2280.01
Operating Expense 1894.21
Net Profit 360.89
Net Profit Margin (%) 15.82
Earnings Per Share (EPS) 13.44
EBITDA 600.22
Effective Tax Rate (%) 26.14
Particulars MAR 2023 (Values in Cr)
Revenue 1973.54
Operating Expense 1669.42
Net Profit 263.25
Net Profit Margin (%) 13.33
Earnings Per Share (EPS) 10.16
EBITDA 463.96
Effective Tax Rate (%) 25.15
Particulars MAR 2022 (Values in Cr)
Revenue 1764.96
Operating Expense 1504.15
Net Profit 218.79
Net Profit Margin (%) 12.39
Earnings Per Share (EPS) 8.68
EBITDA 410.58
Effective Tax Rate (%) 26.04
Particulars MAR 2021 (Values in Cr)
Revenue 1227.40
Operating Expense 1171.33
Net Profit 57.29
Net Profit Margin (%) 4.66
Earnings Per Share (EPS) 6.93
EBITDA 196.79
Effective Tax Rate (%) 32.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 90.54
ROE % 16.13
ROCE % 16.49
Total Debt to Total Equity 0.55
EBITDA Margin 25.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 63.82
ROE % 13.09
ROCE % 14.05
Total Debt to Total Equity 0.68
EBITDA Margin 22.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 272.22
ROE % 2.11
ROCE % 4.43
Total Debt to Total Equity 0.68
EBITDA Margin 15.78
Particulars MAR 2020 (Values in Cr)
Book Value / Share 266.90
ROE % 2.75
ROCE % 5.35
Total Debt to Total Equity 0.65
EBITDA Margin 15.69
Particulars MAR 2019 (Values in Cr)
Book Value / Share 257.06
ROE % 3.96
ROCE % 5.63
Total Debt to Total Equity 0.61
EBITDA Margin 15.28
Particulars MAR 2024 (Values in Cr)
Book Value / Share 106.10
ROE % 13.52
ROCE % 17.19
Total Debt to Total Equity 0.10
EBITDA Margin 26.59
Particulars MAR 2023 (Values in Cr)
Book Value / Share 92.80
ROE % 12.45
ROCE % 15.41
Total Debt to Total Equity 0.14
EBITDA Margin 23.80
Particulars MAR 2022 (Values in Cr)
Book Value / Share 68.70
ROE % 13.57
ROCE % 16.88
Total Debt to Total Equity 0.17
EBITDA Margin 23.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 292.65
ROE % 3.99
ROCE % 6.57
Total Debt to Total Equity 0.08
EBITDA Margin 16.40
Particulars MAR 2020 (Values in Cr)
Book Value / Share 281.74
ROE % 7.70
ROCE % 10.25
Total Debt to Total Equity 0.06
EBITDA Margin 17.80
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 511.80
Total Assets 3145.51
Total Liabilities 3145.51
Total Equity 1616.01
Share Outstanding 253223930
Price to Book Ratio 0.00
Return on Assets (%) 6.23
Return on Capital (%) 8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 289.30
Total Assets 2694.10
Total Liabilities 2694.10
Total Equity 1382.34
Share Outstanding 49585818
Price to Book Ratio 0.00
Return on Assets (%) 1.06
Return on Capital (%) 1.42
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 250.12
Total Assets 2666.28
Total Liabilities 2666.28
Total Equity 1349.53
Share Outstanding 49345003
Price to Book Ratio 0.00
Return on Assets (%) 1.36
Return on Capital (%) 1.84
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 266.45
Total Assets 2430.00
Total Liabilities 2430.00
Total Equity 1295.49
Share Outstanding 49132778
Price to Book Ratio 0.00
Return on Assets (%) 2.11
Return on Capital (%) 2.85
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 260.20
Total Assets 1983.82
Total Liabilities 1983.82
Total Equity 1217.20
Share Outstanding 48494054
Price to Book Ratio 0.00
Return on Assets (%) 1.65
Return on Capital (%) 2.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 959.21
Total Assets 3523.37
Total Liabilities 3523.37
Total Equity 2848.79
Share Outstanding 268507382
Price to Book Ratio 12.48
Return on Assets (%) 10.24
Return on Capital (%) 12.41
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1144.82
Total Assets 3178.70
Total Liabilities 3178.70
Total Equity 2488.86
Share Outstanding 268195172
Price to Book Ratio 5.67
Return on Assets (%) 8.28
Return on Capital (%) 10.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 441.33
Total Assets 2361.33
Total Liabilities 2361.33
Total Equity 1739.75
Share Outstanding 253223930
Price to Book Ratio 0.00
Return on Assets (%) 9.26
Return on Capital (%) 11.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 254.77
Total Assets 2002.11
Total Liabilities 2002.11
Total Equity 1483.63
Share Outstanding 49585818
Price to Book Ratio 0.00
Return on Assets (%) 2.86
Return on Capital (%) 3.8
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 218.76
Total Assets 1957.89
Total Liabilities 1957.89
Total Equity 1422.72
Share Outstanding 49345003
Price to Book Ratio 0.00
Return on Assets (%) 5.24
Return on Capital (%) 7.13
Particulars MAR 2023 (Values in Cr)
Net Income 449.29
Cash from Operations 750.66
Cash from Investing -342.34
Cash from Financing 345.63
Net change in Cash 647.81
Free Cash Flow 986.64
Particulars MAR 2022 (Values in Cr)
Net Income 280.55
Cash from Operations 409.28
Cash from Investing -420.88
Cash from Financing 159.58
Net change in Cash 49.96
Free Cash Flow 683.75
Particulars MAR 2021 (Values in Cr)
Net Income 32.46
Cash from Operations 258.16
Cash from Investing -239.15
Cash from Financing -80.72
Net change in Cash -78.10
Free Cash Flow 403.90
Particulars MAR 2020 (Values in Cr)
Net Income 63.88
Cash from Operations 231.24
Cash from Investing -87.06
Cash from Financing -0.88
Net change in Cash 87.11
Free Cash Flow 419.51
Particulars MAR 2019 (Values in Cr)
Net Income 83.26
Cash from Operations 233.05
Cash from Investing -248.75
Cash from Financing 97.03
Net change in Cash 13.82
Free Cash Flow 532.74
Particulars MAR 2024 (Values in Cr)
Net Income 488.67
Cash from Operations 485.32
Cash from Investing -698.52
Cash from Financing -66.22
Net change in Cash -424.11
Free Cash Flow 671.66
Particulars MAR 2023 (Values in Cr)
Net Income 351.70
Cash from Operations 531.47
Cash from Investing -257.28
Cash from Financing 404.22
Net change in Cash 577.46
Free Cash Flow 647.49
Particulars MAR 2022 (Values in Cr)
Net Income 295.82
Cash from Operations 326.18
Cash from Investing -312.99
Cash from Financing 97.59
Net change in Cash 20.00
Free Cash Flow 390.76
Particulars MAR 2021 (Values in Cr)
Net Income 84.42
Cash from Operations 215.51
Cash from Investing -250.46
Cash from Financing -36.66
Net change in Cash -86.24
Free Cash Flow 241.80
Particulars MAR 2020 (Values in Cr)
Net Income 130.93
Cash from Operations 226.05
Cash from Investing -45.33
Cash from Financing -55.64
Net change in Cash 91.57
Free Cash Flow 243.36
Company Name Price P/E P/B Market Cap 52 Week Low/High
GLOBAL HEALTH LIMITED 1202.50 67.52 11.11 32288.01 615.00 / 1513.75
APOLLO HOSPITALS ENTER. L 6385.00 102.31 13.25 91806.50 4727.00 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 67.50 0.00 1.15 126.51 44.00 / 107.94
SHREE PACETRONIX LTD. 168.15 18.02 4.64 60.52 138.00 / 391.90
TRANSGENE BIOTEK LTD. 9.72 0.00 6.87 73.65 3.62 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
GLOBAL HEALTH LIMITED 1202.50 89.61 11.33 32288.01 615.00 / 1513.75
APOLLO HOSPITALS ENTER. L 6385.00 90.85 11.90 91806.50 4727.00 / 6871.30
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 35.22 0.00 -79.72 26.31 21.00 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4184.20 25.43 5.15 4577.51 2377.20 / 4777.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1211.80
  • 26 Days 1249.60
  • 10 Days 1226.90
  • 50 Days 1279.70
  • 12 Days 1231.70
  • 100 Days 1308.30
  • 20 Days 1252.60
  • 200 Days 777.00
1203.70
PIVOT
First Resistance 1214.40
Second Resistance 1224.70
Third Resistance 1235.40
First Support 1193.40
Second Support 1182.70
Third Support 1172.40
RSI 6.30
MACD -17.87
Commodity Channel Index (CCI) -131.07
ADX 13.39
Williams % R -82.00

Over 1 Month

down

-10.87

Over 3 Months

down

-14.20

Over 6 Months

down

10.11

Over 1 Year

down

71.29

Over 3 Years

down

0.00

Over 5 Years

down

0.00

GLOBAL HEALTH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GLOBAL HEALTH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
46.58
Promoter Holdings
33.04
FII
12.09
DII
8.27
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Naresh Trehan Shareholding of Promoter and Promoter Group 8.8725457E7 33.04
Dunearn Investments (mauritius) Pte Ltd Public Shareholding 3.990099E7 14.86
Sunil Sachdeva Public Shareholding 3.1450743E7 11.71
Rj Corp Limited Public Shareholding 1.7705182E7 6.59
Government Pension Fund Global Public Shareholding 8254664.0 3.07
Polaris Healthcare Investments Pte Ltd Public Shareholding 5000000.0 1.86
Hdfc Mutual Fund - Hdfc Retirement Savings Fund Public Shareholding 3809429.0 1.42
Canara Robeco Mutual Fund A/c Canara Robeco Small Public Shareholding 3746108.0 1.4
Invesco India Focused Fund Public Shareholding 3714738.0 1.38
Polar Capital Funds Plc - Healthcare Opportunities Public Shareholding 3107860.0 1.16
Novo Holdings A/s Public Shareholding 2716376.0 1.01
Rkm Family Trust Shareholding of Promoter and Promoter Group 1000.0 0.0

GLOBAL HEALTH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GLOBAL HEALTH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GLOBAL HEALTH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Global Health Ltd?

Answer Field

The share price of Global Health Ltd for NSE is ₹ 1204.3 and for BSE is ₹ 1201.6.

What is the Market Cap of Global Health Ltd?

Answer Field

The market cap of Global Health Ltd for NSE is ₹ 3,04,95.76 Cr. and for BSE is ₹ 3,04,27.39 Cr. as of now.

What is the 52 Week High and Low of Global Health Ltd?

Answer Field

The 52 Week High and Low of Global Health Ltd for NSE is ₹ 1513.90 and ₹ 655.65 and for BSE is ₹ 1513.75 and ₹ 615.00.

How to Buy Global Health Ltd share?

Answer Field

You can trade in Global Health Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Global Health Ltd?

Answer Field

The 1 year returns on the stock has been 71.29%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader